As of 2025-07-15, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -6.06 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.22 USD, the upside of Sana Biotechnology Inc is -243.63%.
Based on its market price of 4.22 USD and our intrinsic valuation, Sana Biotechnology Inc (SANA) is overvalued by 243.63%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.06 - -6.06 | -6.06 | -243.63% |
| P/E | (17.26) - (23.66) | (17.46) | -513.7% |
| DDM - Stable | (8.29) - (24.25) | (16.27) | -485.6% |
| DDM - Multi | (9.06) - (21.36) | (12.81) | -403.6% |
| Market Cap (mil) | 726.41 |
| Beta | 0.71 |
| Outstanding shares (mil) | 172.13 |
| Enterprise Value (mil) | 630.27 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.36% |
| Cost of Debt | 5.00% |
| WACC | 7.52% |